The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Abstract
A long-standing paradox in cellular immunology concerns the conditional requirement for CD4+ T-helper (T(H)) cells in the priming of cytotoxic CD8+ T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4+ T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T(H) cells. A clearer understanding of the contribution of T(H) cells to CTL development has been hampered by the fact that most T(H)-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T(H)-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T(H)-dependent and T(H)-independent CTLs and find in both cases that CD4+ T cells are dispensable for primary expansion of CD8+ T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T(H) cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8+ T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter cell death is mediated by expression of the death ligand TRAIL, which triggers apoptosis in the helpless CTL as well as other activated T cells70,72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“In support of this, TRAIL-deficient mice were resistant to tolerance induction by intravenously injected apoptotic cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“As a result, the CD8+ T cells produce TRAIL upon re-exposure to antigen, which acts to inhibit immunization for cell-mediated responses (that is, mediate tolerance).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“DC that have engulfed necrotic cells present antigen to both CD4+ and CD8+ T cells, however those that engulf apoptotic cells present antigen to CD8+ T cells but not CD4+ T cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Self-citationA conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,091
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Although transition through these stages was thought to be governed by the presence and eventual elimination of antigen, mounting evidence suggests that CD8 p T-cell development is guided by an instructional programme that, once set into motion during priming, is executed independentl”
BackgroundDialynas, D. P., Quan, Z., Wall, K. A., Pierrès, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,265
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 843
Self-citationT Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 739
Cited by
Sorted by citations
Items 401–500 of 1,000
Vaccines Based on Novel Adeno-Associated Virus Vectors Elicit Aberrant CD8+T-Cell Responses in Mice
Lin, J., Zhi, Y., Mays, L., & Wilson, J. M. (2007) · Journal of Virology · doi:10.1128/jvi.01253-07 · Cited by 66
Zloza, A., Kohlhapp, F. J., Lyons, G. E., Schenkel, J. M., Moore, T. V., Lacek, A. T., O’Sullivan, J. A., Varanasi, V., Williams, J. W., Jagoda, M. C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2683 · Cited by 67
Richards, K. A., Chaves, F. A., Krafcik, F. R., Topham, D. J., Lazarski, C. A., & Sant, A. J. (2007) · Journal of Virology · doi:10.1128/jvi.02834-06 · Cited by 66
Liu, J., Curtin, J. C., You, D., Hillerman, S. M., Li-Wang, B., Eraslan, R., Xie, J., Swanson, J., Ho, C., Oppenheimer, S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212670 · Cited by 67
Longman, R., Braun, D., Pellegrini, S., Rice, C. M., Darnell, R. B., & Albert, M. L. (2006) · Blood · doi:10.1182/blood-2006-05-023465 · Cited by 70
Modelling HIV immune response and validation with clinical data
Banks, H. T., Davidian, M., Hu, S., Kepler, G. M., & Rosenberg, E. S. (2008) · Journal of Biological Dynamics · doi:10.1080/17513750701813184 · Cited by 65
Haabeth, O. A. W., Fauskanger, M., Manzke, M., Lundin, K. U., Corthay, A., Bogen, B., & Tveita, A. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2426 · Cited by 68
WT 1 vaccination in AML and MDS : A pilot trial with synthetic analog peptides
Brayer, J. B., Lancet, J. E., Powers, J. J., List, A. F., Balducci, L., Komrokji, R. S., & Pinilla-Ibarz, J. A. (2015) · American Journal of Hematology · doi:10.1002/ajh.24014 · Cited by 66
Yamaguchi, S., Tatsumi, T., Takehara, T., Sakamori, R., Uemura, A., Mizushima, T., Ohkawa, K., Storkus, W. J., & Hayashi, N. (2007) · Cancer · doi:10.1002/cncr.22958 · Cited by 64
Vaccine Development Against Leishmania donovani
Das, A., & Ali, N. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00099 · Cited by 64
Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer
Wang, R. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.009 · Cited by 64
Vinod, N., Hwang, D., Azam, S. H., Van Swearingen, A. E. D., Wayne, E., Fussell, S. C., Sokolsky-Papkov, M., Pecot, C. V., & Kabanov, A. V. (2020) · Science Advances · doi:10.1126/sciadv.aba5542 · Cited by 63
HUANG, J., CAO, Y., Du, J., Bu, X., MA, R., & Wu, C. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.047 · Cited by 63
Choo, D. K., Murali‐Krishna, K., Anita, R., & Ahmed, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001421 · Cited by 64
CD4 + T help promotes influenza virus-specific CD8 + T cell memory by limiting metabolic dysfunction
Cullen, J. G., McQuilten, H. A., Quinn, K. M., Olshansky, M., Russ, B. E., Morey, A., Wei, S., Prier, J. E., Gruta, N. L. L., Doherty, P. C., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1808849116 · Cited by 65
CD8 T cell memory development: CD4 T cell help is appreciated
Khanolkar, A., Badovinac, V. P., & Harty, J. T. (2007) · Immunologic Research · doi:10.1007/s12026-007-0081-4 · Cited by 63
Helper Requirements for Generation of Effector CTL to Islet β Cell Antigens
Behrens, G. M. N., Li, M., Davey, G. M., Allison, J., Flavell, R. A., Carbone, F., & Heath, W. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5420 · Cited by 63
Derrick, S. C., Repique, C. J., Snoy, P. J., Yang, A. L., & Morris, S. L. (2004) · Infection and Immunity · doi:10.1128/iai.72.3.1685-1692.2004 · Cited by 63
Gruber, I. V., Landenberger, N., Staebler, A., Hahn, M., Wallwiener, D. R., & Fehm, T. N. (2013) · PubMed · Cited by 62
Braeckel, E. V., Bourguignon, P., Koutsoukos, M., Clément, F., Janssens, M., Carletti, I., Collard, A., Demoitié, M., Voss, G., Leroux-Roels, G. G., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq160 · Cited by 62
Korenkov, D. A., Николаевна, И.-С. И., & Георгиевна, Р. Л. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1541407 · Cited by 62
Gottschalk, C., Mettke, E., & Kurts, C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00379 · Cited by 64
CD8 T cell responses to influenza virus infection in aged mice
Jiang, J. K., Fisher, E. M., & Murasko, D. M. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.02.001 · Cited by 61
TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help
Hervás‐Stubbs, S., Olivier, A., Boisgérault, F., Thiéblemont, N., & Leclerc, C. (2007) · Blood · doi:10.1182/blood-2006-10-053256 · Cited by 61
Cytosolic Entry Controls CD8+-T-Cell Potency during Bacterial Infection
Bahjat, K. S., Liu, W., Lemmens, E. E., Schoenberger, S. P., Portnoy, D. A., Dubensky, T. W., & Brockstedt, D. G. (2006) · Infection and Immunity · doi:10.1128/iai.01088-06 · Cited by 61
Self-citationGoon, P. K. C., Igakura, T., Hanon, E., Mosley, A. J., Asquith, B., Gould, K. G., Taylor, G. P., Weber, J. N., & Bangham, C. R. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9716-9722.2003 · Cited by 61
EBV-Induced Human CD8+ NKT Cells Suppress Tumorigenesis by EBV-Associated Malignancies
He, Y., Ruijing, X., Li, L., Ji, X., Rui, Z., Wang, Y., Lijun, Z., Chunxian, D., Xinti, T., Wei, X., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0828 · Cited by 62
Misumi, I., & Whitmire, J. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302661 · Cited by 61
Aged Mice Develop Protective Antitumor Immune Responses with Appropriate Costimulation
Lustgarten, J., Dominguez, A. L., & Thoman, M. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4510 · Cited by 61
The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses
Sağ, D., Ayyıldız, Z. Ö., Günalp, S., & Wingender, G. (2019) · Cancers · doi:10.3390/cancers11101469 · Cited by 64
Schuhmacher, J., Heidu, S., Balchen, T., Richardson, J. R., Schmeltz, C., Sonne, J., Schweiker, J., Rammensee, H., Straten, P. T., Røder, M. A., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001157 · Cited by 62
Fischer, T., Planz, O., Stitz, L., & Rziha, H.-J. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9312-9323.2003 · Cited by 61
de Arruda, L. B., Chikhlikar, P. R., August, J. T., & Marques, E. T. A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01823.x · Cited by 61
CD8 + T-Cell Memory: The Why, the When, and the HowPreprint
Turner, S. T., Bennett, T. J., & Gruta, N. L. L. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a038661 · Cited by 65
Shahbaz, S., Xu, L., Sligl, W., Osman, M. S., Bozorgmehr, N., Mashhouri, S., Redmond, D., Rosero, E. P., Walker, J. W. T., & Elahi, S. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100446 · Cited by 63
Spear, P., Barber, A., & Sentman, C. L. (2013) · OncoImmunology · doi:10.4161/onci.23564 · Cited by 61
Smith, J. M., Amara, R. R., Campbell, D. T., Xu, Y., Patel, M., Sharma, S., Butera, S. T., Ellenberger, D. L., Yi, H. L., Chennareddi, L. S., et al. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2004.20.1335 · Cited by 60
MhcDRB‐sequences from cynomolgus macaques (Macaca fascicularis) of different origin
Leuchte, N., Berry, N. J., Köhler, B., Almond, N. M., Grand, R. L., Thorstensson, R., Titti, F., & Sauermann, U. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.0222.x · Cited by 60
CD4+ and CD8+ T cell–dependent antiviral immunity requires STIM1 and STIM2
Shaw, P. J., Weidinger, C., Vaeth, M., Luethy, K., Kaech, S. M., & Feske, S. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76602 · Cited by 62
Sun, Y., Schmitz, J. E., Buzby, A. P., Barker, B. R., Rao, S. S., Xu, L., Yang, Z., Mascola, J. R., Nabel, G. J., & Letvin, N. L. (2006) · Journal of Virology · doi:10.1128/jvi.01458-06 · Cited by 60
IL-2 Is Required for the Activation of Memory CD8+ T Cells via Antigen Cross-Presentation
Blachère, N. E., Morris, H. K., Braun, D., Jusforgues-Saklani, H., Santo, J. P. D., Darnell, R. B., & Albert, M. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7288 · Cited by 63
Requirement for CD70 in CD4+ Th Cell-Dependent and Innate Receptor-Mediated CD8+ T Cell Priming
Taraban, V. Y., Rowley, T. F., Tough, D. F., & Al‐Shamkhani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2969 · Cited by 60
Badovinac, V. P., Messingham, K. N., Griffith, T. S., & Harty, J. T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.999 · Cited by 64
Optimizing the manufacturing and antitumour response of CAR T therapy
Liu, Y., Sperling, A. S., Smith, E. L., & Mooney, D. J. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00031-x · Cited by 60
The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer
Seya, T., & Matsumoto, M. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0652-9 · Cited by 59
Overstreet, M. G., Chen, Y., Cockburn, I. A., Tse, S., & Zavala, F. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015948 · Cited by 64
Brichard, V. G., & Lejeune, D. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.951 · Cited by 59
Saout, C. L., Mennechet, S., Taylor, N. N., & Hernández, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807743105 · Cited by 59
Differential Immunogenicity of HIV‐1 Clade C Proteins in Eliciting CD8+and CD4+Cell Responses
Ramduth, D., Chetty, P., Mngquandaniso, N. C., Nene, N., Harlow, J., Honeyborne, I., Ntumba, N., Gappoo, S., Henry, C., Jeena, P. M., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/496894 · Cited by 59
Chiang, C. L.-L., Hagemann, A. R., Leskowitz, R. M., Mick, R., Garrabrant, T. A., Czerniecki, B. J., Kandalaft, L. E., Powell, D. J., & Coukos, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028732 · Cited by 58
Shafer-Weaver, K., Watkins, S. K., Anderson, M. J. M., Draper, L. J., Malyguine, A. M., Alvord, W. G., Greenberg, N. M., & Hurwitz, A. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4516 · Cited by 58
RetractedJing, L., Davies, D. H., Chong, T. M., Chun, S., McClurkan, C. L., Huang, J., Story, B. T., Molina, D. M., Hirst, S., Felgner, P. L., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00453-08 · Cited by 58
Sharma, R. K., Schabowsky, R.-H., Srivastava, A. K., Elpek, K. G., Madireddi, S., Zhao, H., Zhong, Z., Miller, R. W., MacLeod, K. J., Yolcu, E. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4480 · Cited by 61
Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection
Guvenel, A., Jóźwik, A., Ascough, S., Ung, S. K. A., Paterson, S., Kalyan, M., Gardener, Z., Bergstrom, E., Kar, S., Habibi, M. S., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci131696 · Cited by 60
Classification of Human Leukocyte Antigen (HLA) Supertypes
Wang, M., & Claësson, M. H. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1115-8_17 · Cited by 61
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals
Jobin, K., Seetharama, D., Rüttger, L., Fenton, C., Kharybina, E., Wirsching, A., Huang, A., Knöpper, K., Kaisho, T., Busch, D. H., et al. (2025) · Science · doi:10.1126/science.adq1405 · Cited by 57
DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance
Chaise, C., Buchan, S. L., Rice, J., Marquet, J., Rouard, H., Kuentz, M., Vittes, G. E., Molinier‐Frenkel, V., Farcet, J., Stauss, H. J., et al. (2008) · Blood · doi:10.1182/blood-2008-02-137695 · Cited by 57
Lee, S., Stokes, K. L., Currier, M. G., Sakamoto, K., Lukacs, N. W., Celis, E., & Moore, M. L. (2012) · Journal of Virology · doi:10.1128/jvi.01770-12 · Cited by 57
Kitchen, S. G., Whitmire, J. K., Jones, N. R., Galić, Z., Ramirez, C. M., Ahmed, R., & Zack, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406603102 · Cited by 57
Bioley, G., Jandus, C., Tuyaerts, S., Rimoldi, D., Kwok, W. W., Speiser, D. E., Tiercy, J., Thielemans, K., Cerottini, J., & Romero, P. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6769 · Cited by 57
A fully human IgG1 anti‐PD‐L1 MAb in an in vitro assay enhances antigen‐specific T‐cell responses
Grenga, I., Donahue, R. N., Lepone, L. M., Richards, J., & Schlom, J. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.27 · Cited by 56
Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells
Provine, N. M., Larocca, R. A., Aïd, M., Penaloza‐MacMaster, P., Badamchi-Zadeh, A., Borducchi, E. N., Yates, K. B., Abbink, P., Kirilova, M., Ng’ang’a, D., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600591 · Cited by 58
Harnessing neoantigen specific CD4 T cells for cancer immunotherapy
Brightman, S. E., Naradikian, M. S., Miller, A. M., & Schoenberger, S. P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ri0220-603rr · Cited by 57
Self-citationIL-12-Programmed Long-Term CD8+ T Cell Responses Require STAT4
Li, Q., Eppolito, C., Odunsi, K. O., & Shrikant, P. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7618 · Cited by 58
CD8+ T-cell memory: only the good ones last
Northrop, J. K., & Shen, H. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.05.004 · Cited by 56
Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B
Chen, Y., Li, X., Ye, B., Yang, X., Wu, W., Chen, B., Pan, X., Cao, H., & Li, L. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.04.008 · Cited by 55
DNA vaccines against human immunodeficiency virus type 1
Estcourt, M. J., McMichael, A. J., & Hanke, T. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00151.x · Cited by 55
Zheng, N. N., Kiviat, N. B., Sow, P. S., Hawes, S. E., Wilson, A. J., Agne, H. D., Critchlow, C. W., Gottlieb, G. S., Musey, L. K., & McElrath, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13934-13942.2004 · Cited by 55
T cell memory and protective immunity by vaccination: is more better?
Zanetti, M., & Franchini, G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.09.004 · Cited by 55
Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy
Bonehill, A., Heirman, C., & Thielemans, K. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.713 · Cited by 55
Fujiki, F., Oka, Y., Tsuboi, A., Kawakami, M., Kawakatsu, M., Nakajima, H., Elisseeva, O. A., Harada, Y., Ito, K., Li, Z., et al. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.cji.0000211337.91513.94 · Cited by 55
Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals
Jin, J., Kim, C., Xia, Q., Gould, T. M., Cao, W., Zhang, H., Li, X., Weiskopf, D., Grifoni, A., Sette, A., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg0791 · Cited by 56
Pagadala, M. S., Sears, T. J., Wu, V. H., Pérez‐Guijarro, E., Kim, H., Castro, A., Talwar, J. V., González-Colín, C., Cao, S., Schmiedel, B. J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38271-5 · Cited by 54
Deficiency of HIV-Gag-Specific T Cells in Early Childhood Correlates with Poor Viral Containment
Huang, S., Dunkley-Thompson, J., Tang, Y., Macklin, E. A., Steel-Duncan, J., Singh-Minott, I., Ryland, E. G., Smikle, M., Walker, B. D., Christie, C. D. C., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.8103 · Cited by 54
Willoughby, J. E., Kerr, J. P., Rogel, A., Taraban, V. Y., Buchan, S. L., Johnson, P., & Al‐Shamkhani, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301217 · Cited by 54
HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia
Rutten, C. E., van Luxemburg-Heijs, S. A. P., Griffioen, M., Marijt, E. W. A., Jedema, I., Heemskerk, M. H. M., Posthuma, E. F. M., Willemze, R., & Falkenburg, J. H. F. (2008) · Leukemia · doi:10.1038/leu.2008.90 · Cited by 54
Pearce, E. L., Shedlock, D. J., & Shen, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2494 · Cited by 54
Campi, G., Crosti, M., Consogno, G., Facchinetti, V., Conti‐Fine, B. M., Longhi, R., Casorati, G., Dellabona, P., & Protti, M. P. (2003) · PubMed · Cited by 54
The Fate of Low Affinity Tumor-Specific CD8+ T Cells in Tumor-Bearing Mice
Lyman, M. A., Nugent, C., Marquardt, K., Biggs, J., Pamer, E. G., & Sherman, L. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2563 · Cited by 54
Speiser, D. E., Pittet, M. J., Rimoldi, D., Guillaume, P., Luescher, I. F., Líénard, D., Lejeune, F. J., Cerottini, J., & Romero, P. J. (2003) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.09.010 · Cited by 54
Wells, J. W., Cowled, C. J., Farzaneh, F., & Noble, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3422 · Cited by 53
HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells
Dai, B., Yang, L., Yang, H., Hu, B., Baltimore, D., & Wang, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911742106 · Cited by 53
Vaccari, M., Mattapallil, J. J., Song, K., Tsai, W.-P., Hryniewicz, A., Venzon, D. J., Zanetti, M., Reimann, K. A., Roederer, M., & Franchini, G. (2008) · Journal of Virology · doi:10.1128/jvi.00893-08 · Cited by 53
FoxP3+ regulatory CD4 T cells control the generation of functional CD8 memory
de Herve, M. G. D. G., Jaafoura, S., Vallée, M., & Taoufik, Y. (2012) · Nature Communications · doi:10.1038/ncomms1992 · Cited by 60
BenMarzouk‐Hidalgo, O. J., Cisneros, J. M., Cordero, E., Martín‐Peña, A., Sánchez, B., Martín‐Gandul, C., Gentil, M. A., Gómez‐Bravo, M. Á., Lage, E., & Pérez‐Romero, P. (2011) · Transplantation · doi:10.1097/tp.0b013e3182115ba2 · Cited by 53
Toll-like Receptor Ligands Energize Peptide Vaccines through Multiple Paths
Celis, E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1652 · Cited by 52
Immunological challenges for peptide-based immunotherapy in glioblastoma
Mohme, M., Neidert, M. C., Regli, L., Weller, M., & Martinꝉ, R. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.08.008 · Cited by 53
Cancer vaccines: translation from mice to human clinical trials
Maeng, H. M., Terabe, M., & Berzofsky, J. A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.001 · Cited by 53
Cooperation between CD4 and CD8 T cells for anti‐tumor activity is enhanced by OX40 signals
Song, A., Song, J. J., Tang, X., & Croft, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200636957 · Cited by 52
AFP-specific CD4+ Helper T-cell Responses in Healthy Donors and HCC Patients
Evdokimova, V. N., Liu, Y., Potter, D. M., & Butterfield, L. H. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31802fd8e2 · Cited by 52
Sant, A. J., Chaves, F. A., Krafcik, F. R., Lazarski, C. A., Menges, P. R., Richards, K. A., & Weaver, J. M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.357 · Cited by 52
Bender, A., Karbach, J., Neumann, A., Jäger, D., Al-Batran, S. E., Atmaca, A., Weidmann, E., Biskamp, M., Gnjatic, S., Pan, L. S., et al. (2007) · PubMed Central · Cited by 52
Macedo, C., Webber, S. A., Donnenberg, A. D., Popescu, I., Hua, Y., Green, M., Rowe, D., Smith, L., Brooks, M. M., & Metes, D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001024 · Cited by 52
Rocha, B., & Tanchot, C. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.08.011 · Cited by 52
T‐cell help permits memory CD8+ T‐cell inflation during cytomegalovirus latency
Walton, S. M., Torti, N., Mandarić, S., & Oxenius, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141575 · Cited by 51
Nchinda, G., Amadu, D., Trumpfheller, C., Mizenina, O. A., Überla, K., & Steinman, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000621107 · Cited by 52
Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines
Lau, Y. F., Deliyannis, G., Zeng, W., Mansell, A. S., Jackson, D. C., & Brown, L. E. (2006) · International Immunology · doi:10.1093/intimm/dxl114 · Cited by 51
CD4+ T Cell-Derived IL-2 Signals during Early Priming Advances Primary CD8+ T Cell Responses
Lai, Y., Lin, C.-C. J., Liao, W.-J., Tang, C., & Chen, S.-C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007766 · Cited by 53
Welters, M. J. P., Bijker, M. S., van den Eeden, S. J. F., Franken, K. L. M. C., Melief, C. J. M., Offringa, R., & van der Burg, S. H. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.10.049 · Cited by 51
Differences in maintenance of CD8+ and CD4+ bacteria‐specific effector‐memory T cell populations
Schiemann, M., Busch, V., Linkemann, K., Huster, K. M., & Busch, D. H. (2003) · European Journal of Immunology · doi:10.1002/eji.200324224 · Cited by 51
Metadata
- Authors
- Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P.
- Affiliations
- La Jolla Institute for Immunology (US)
- Corresponding author
- Schoenberger, Stephen P.
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6925
- Pages
- 852-856
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1493822493
- Cited by
- 1,635
- References
- 28
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 37 · 2023: 46 · 2022: 37 · 2021: 42 · 2020: 58 · 2019: 42 · 2018: 52 · 2017: 36 · 2016: 41 · 2015: 61 · 2014: 63 · 2013: 63 · 2012: 71
- FWCI
- 46.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- CD4+ T cells, CD8+ T cells, cytotoxic T lymphocytes, T helper cells, secondary immune response, T cell memory, T cell help, cross-priming, antigen-presenting cells, T cell differentiation
- MeSH terms
- Animals, Antigens, Cell Line, Cytotoxicity, Immunologic, Flow Cytometry, T-Lymphocytes, Helper-Inducer, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, T-Lymphocytes, Cytotoxic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review